Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine with or without delayed dexamethasone vs dexamethasone alone for delayed chemotherapy-induced nausea and vomiting in gynecologic cancers
2013-005309-30Phase 3Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of olanzapine in gynecological cancer (3 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: CP. Started Jan 2014; status: completed.
02
Drugs
olanzapine
03
Conditions
gynecological cancer
Beyond the preview
Go deeper on 2013-005309-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-005309-30.